Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction

被引:12
|
作者
Daou, Daniel [1 ]
Gillette, Thomas G. [1 ]
Hill, Joseph A. [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX USA
基金
美国国家卫生研究院;
关键词
heart failure; inflammation; meta-inflammation; myocardial remodeling; EPICARDIAL ADIPOSE-TISSUE; TUMOR-NECROSIS-FACTOR; HIGH-DENSITY-LIPOPROTEINS; CLONAL HEMATOPOIESIS; CARDIAC-HYPERTROPHY; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; MACROPHAGE POLARIZATION; DIASTOLIC DYSFUNCTION;
D O I
10.1152/physiol.00004.2023
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) is now the most common form of heart failure and a significant public health concern for which limited effective therapies exist. Inflammation triggered by comorbidity burden is a critical element of HFpEF pathophysiology. Here, we discuss evidence for comorbidity-driven systemic and myocardial inflammation and the mechanistic role of inflammation in pathological myocardial remodeling in HFpEF.
引用
收藏
页码:217 / 230
页数:14
相关论文
共 50 条
  • [41] Heart failure with preserved ejection fraction
    Reda, S.
    Motloch, L. J.
    Hoppe, U. C.
    KARDIOLOGE, 2011, 5 (03): : 237 - 243
  • [42] Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction
    Plitt, Gilman D.
    Spring, Jordan T.
    Moulton, Michael J.
    Agrawal, Devendra K.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2018, 16 (08) : 579 - 589
  • [43] Heart Failure with Preserved Ejection Fraction
    Meyer, Adam
    Kerrigan, Martin
    HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 283 - 296
  • [44] Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach
    Hage, Camilla
    Michaelsson, Erik
    Linde, Cecilia
    Donal, Erwan
    Daubert, Jean-Claude
    Gan, Li-Ming
    Lund, Lars H.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2017, 10 (01)
  • [45] Mechanisms of Sinoatrial Node Dysfunction in Heart Failure With Preserved Ejection Fraction
    Mesquita, Thassio
    Zhang, Rui
    Cho, Jae Hyung
    Zhang, Rui
    Lin, Yen-Nien
    Sanchez, Lizbeth
    Goldhaber, Joshua, I
    Yu, Joseph K.
    Liang, Jialiu A.
    Liu, Weixin
    Trayanova, Natalia A.
    Cingolani, Eugenio
    CIRCULATION, 2022, 145 (01) : 45 - 60
  • [46] Current understanding of heart failure with preserved ejection fraction
    Desai, Akshay
    CURRENT OPINION IN CARDIOLOGY, 2007, 22 (06) : 578 - 585
  • [47] Lipotoxicity: a driver of heart failure with preserved ejection fraction?
    Leggat, Jennifer
    Bidault, Guillaume
    Vidal-Puig, Antonio
    CLINICAL SCIENCE, 2021, 135 (19) : 2265 - 2283
  • [48] Heart Failure With Preserved Ejection Fraction What Is in a Name?
    Jumean, Marwan F.
    Konstam, Marvin A.
    CARDIOLOGY IN REVIEW, 2015, 23 (04) : 161 - 167
  • [49] Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
    Henry, John Aaron
    Couch, Liam S.
    Rider, Oliver J.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [50] Novel Biomarkers in Heart Failure with Preserved Ejection Fraction
    Shah, Kevin S.
    Maisel, Alan S.
    HEART FAILURE CLINICS, 2014, 10 (03) : 471 - +